These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2033117)

  • 1. Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera.
    Adams D; Kuntzer T; Burger D; Chofflon M; Magistris MR; Regli F; Steck AJ
    J Neuroimmunol; 1991 Jun; 32(3):223-30. PubMed ID: 2033117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants.
    Salazar-Grueso EF; Routbort MJ; Martin J; Dawson G; Roos RP
    Ann Neurol; 1990 May; 27(5):558-63. PubMed ID: 2113790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies.
    Pestronk A
    Muscle Nerve; 1991 Oct; 14(10):927-36. PubMed ID: 1658646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum IgM anti-GM1 ganglioside antibodies in lower motor neuron syndromes.
    Niebroj-Dobosz I; Janik P; Kwieciński H
    Eur J Neurol; 2004 Jan; 11(1):13-6. PubMed ID: 14692882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates.
    Pestronk A; Choksi R
    Neurology; 1997 Nov; 49(5):1289-92. PubMed ID: 9371910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis.
    Pestronk A; Adams RN; Clawson L; Cornblath D; Kuncl RW; Griffin D; Drachman DB
    Neurology; 1988 Sep; 38(9):1457-61. PubMed ID: 3412595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sensitivity and specificity of anti-GM1 antibody testing.
    Taylor BV; Gross L; Windebank AJ
    Neurology; 1996 Oct; 47(4):951-5. PubMed ID: 8857725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis.
    Pestronk A; Adams RN; Cornblath D; Kuncl RW; Drachman DB; Clawson L
    Ann Neurol; 1989 Jan; 25(1):98-102. PubMed ID: 2913936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower motor neuron syndrome associated with IgG anti-GM1 antibodies revisited.
    Yuki N; Yanaka C; Sudo M; Funakoshi M; Ishida H; Mori M; Kanda F; Hirata K
    J Neuroimmunol; 2014 Jul; 272(1-2):62-6. PubMed ID: 24841627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlations of anti-GM1 antibodies in amyotrophic lateral sclerosis and neuropathies.
    Lamb NL; Patten BM
    Muscle Nerve; 1991 Oct; 14(10):1021-7. PubMed ID: 1944401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-ganglioside antibodies in peripheral neuropathy.
    McCombe PA; Wilson R; Prentice RL
    Clin Exp Neurol; 1992; 29():182-8. PubMed ID: 1343861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor neuropathies and serum IgM binding to NS6S heparin disaccharide or GM1 ganglioside.
    Pestronk A; Chuquilin M; Choksi R
    J Neurol Neurosurg Psychiatry; 2010 Jul; 81(7):726-30. PubMed ID: 20581137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to GM1 ganglioside: different reactivity to GM1-liposomes in amyotrophic lateral sclerosis and lower motor neuron disorders.
    Li F; Pestronk A
    J Neurol Sci; 1991 Aug; 104(2):209-14. PubMed ID: 1940974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of neurologic disease associated with anti-GM1 antibodies.
    Sadiq SA; Thomas FP; Kilidireas K; Protopsaltis S; Hays AP; Lee KW; Romas SN; Kumar N; van den Berg L; Santoro M
    Neurology; 1990 Jul; 40(7):1067-72. PubMed ID: 2162499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls.
    Bansal AS; Abdul-Karim B; Malik RA; Goulding P; Pumphrey RS; Boulton AJ; Holt PL; Wilson PB
    J Clin Pathol; 1994 Apr; 47(4):300-2. PubMed ID: 8027366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies.
    Pestronk A; Chaudhry V; Feldman EL; Griffin JW; Cornblath DR; Denys EH; Glasberg M; Kuncl RW; Olney RK; Yee WC
    Ann Neurol; 1990 Mar; 27(3):316-26. PubMed ID: 2327739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block.
    Santoro M; Thomas FP; Fink ME; Lange DJ; Uncini A; Wadia NH; Latov N; Hays AP
    Ann Neurol; 1990 Sep; 28(3):373-7. PubMed ID: 2132741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer.
    Harvey GK; Toyka KV; Zielasek J; Kiefer R; Simonis C; Hartung HP
    Muscle Nerve; 1995 Apr; 18(4):388-94. PubMed ID: 7715623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement and significance of antibodies against GM1 ganglioside. Report of a workshop, 18 April 1989, Chicago, IL, U.S.A.
    Marcus DM; Latov N; Hsi BP; Gillard BK
    J Neuroimmunol; 1989 Dec; 25(2-3):255-9. PubMed ID: 2584398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside.
    Pestronk A; Cornblath DR; Ilyas AA; Baba H; Quarles RH; Griffin JW; Alderson K; Adams RN
    Ann Neurol; 1988 Jul; 24(1):73-8. PubMed ID: 2843079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.